Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

Recalls / PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer

PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer

Drugs · Last updated 2020-10-27

Why it was recalled

Product safety

Source

Other Recent Recalls

Apo-Semaglutide Injection

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-09-24

Moderate health risk

Novo-Gesic Forte 500 mg tablets (acetaminophen)

Generic acetaminophen by Teva recalled because it may contain foreign material

Type I2026-09-10

Highest health risk

JAMP Temozolomide

JAMP Temozolomide: Out-of-Specification (Assay)

Type II2026-08-31

Moderate health risk

Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.